Avemio AG (XTER:AV2) Research & Development: €0.00 Mil (TTM As of Jun. 2025)


XTER:AV2 Avemio AG XTER:AV2
36 GF Score
Price €0.62
! 3 Warning Signs
View Full Analysis

What is Avemio AG Research & Development?

Avemio AG XTER:AV2 36 Research & Development is €0.00 Mil as of Jun. 2025. GuruFocus rates XTER:AV2 with a GF Score™ of 36/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Avemio AG's Research & Development for the six months ended in Jun. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was €0.00 Mil.

Avemio AG  (XTER:AV2) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Avemio AG Research & Development Related Terms

Avemio AG Research & Development Historical Data

* Premium members only.

The historical data trend for Avemio AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avemio AG Research & Development Chart

Avemio AG Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Avemio AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XTER:AV2
36GF Score
Avemio AG XTER:AV2
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avemio AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Avemio AG (XTER:AV2) has a Research & Development of €0.00 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on Avemio AG and its competitors.
Is Avemio AG's Research & Development too high?
Avemio AG's current Research & Development is €0.00 Mil. Overall, Avemio AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Avemio AG's Research & Development compare to VRSK and EFX?
Avemio AG's Research & Development of €0.00 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Business Services company?
A good Research & Development depends on the Business Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Avemio AG and its competitors. Avemio AG's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avemio AG stock overvalued right now?
Avemio AG (XTER:AV2) has a current Research & Development of €0.00 Mil. The current Research & Development is €0.00 Mil. Avemio AG's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Avemio AG (XTER:AV2), the current Research & Development is €0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avemio AG Business Description

Other Exchanges AV2:Germany
Address Konigsallee 60f, Dusseldorf, DEU, 40212
Avemio AG Formerly Palgon AG provides management consulting services. It offers marketing, distribution, and other services in the field of information technology, including the Internet and data processing and related fields. Further, the group is also involved in acquiring, selling, renting, and managing real estate.
36GF Score

Get the complete analysis for XTER:AV2

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.62
Price